Logo
x

Search

Subscribe Now

Frontotemporal Dementia-Granulin

Takeda Exercises its Option with Denali to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN) for Frontotemporal Dementia-Granulin

Takeda Exercises its Option with Denali to Co-Develop and Co-Commercialize DNL593 (PTV:PGRN) for Frontotemporal Dementia-Granulin

  • November 18, 2021
Merck KGaA Collaborated with Burning Rock for Liquid-biopsy Based CDx Development

Merck KGaA Collaborated with Burning Rock for Liquid-biopsy Based CDx Development

  • November 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.